VEGFA and ovarian carcinoma: The most common onset of thrombosis in ovarian cancer is within the first year after diagnosis, and pelvic surgery, chemotherapy, and anti-vascular endothelial growth factor (VEGF) treatment are associated with its occurrence [31,32,33].